Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease-Reference-Cited by-同舟云学术

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease

Published:2020-11-29 Issue:1 Volume:8 Page:259-265
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann. Clin. Transl. Neurol.

Author:

Hansson Oskar¹²^ORCID,Cullen Nicholas²³^ORCID,Zetterberg Henrik⁴⁵⁶⁷,Blennow Kaj⁴⁵,Mattsson‐Carlgren Niklas²³⁸^ORCID,

Affiliation:

1. Memory Clinic Skåne University Hospital Lund Sweden

2. Clinical Memory Research Unit Department of Clinical Sciences Lund University Malmö Sweden

3. Wallenberg Centre for Molecular Medicine Lund University Lund Sweden

4. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

5. Department of Psychiatry and NeurochemistryInstitute of Neuroscience and PhysiologySahlgrenska AcademyUniversity of Gothenburg Gothenburg Sweden

6. Department of Neurodegenerative Disease UCL Institute of Neurology London United Kingdom

7. UK Dementia Research Institute at UCL London United Kingdom

8. Department of Neurology Skåne University Hospital Lund Sweden

Funder

Vetenskapsrådet

Knut och Alice Wallenbergs Stiftelse

Hjärnfonden

Sveriges Läkarförbund

European Research Council

National Institutes of Health

National Institute on Aging

National Institute of Biomedical Imaging and Bioengineering

AbbVie

BioClinica

Biogen

Bristol-Myers Squibb

Eli Lilly and Company

Roche

Genentech

Fujirebio Europe

GE Healthcare

Johnson and Johnson

Novartis Pharmaceuticals Corporation

Pfizer

Takeda Pharmaceutical Company

Northern California Institute for Research and Education

University of Southern California

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51253

Reference15 articles.

1. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

2. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

3. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

4. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

5. Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort;Alzheimer's & Dementia;2024-01-06

2. Risk of Alzheimer’s Disease is Associated with Longitudinal Changes in Plasma Biomarkers in the Multiethnic Washington Heights, Inwood Columbia Aging Project Cohort;2023-08-16

3. Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer’s disease: A biochemical analysis in Pakistani population;Saudi Pharmaceutical Journal;2023-07

4. Comparison of the clinical value of MRI and plasma markers for cognitive impairment in patients aged ≥75 years: a retrospective study;PeerJ;2023-06-22

5. Blood biomarkers for Alzheimer’s disease in clinical practice and trials;Nature Aging;2023-05-18